Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Mersana Therapeutics Q3 EPS $(0.63) Misses $(0.58) Estimate

Mersana Therapeutics (NASDAQ:MRSN) reported quarterly losses of $(0.63) per share which missed the analyst consensus estimate of $(0.58) by 8.62 percent. This is a 90.91 percent decrease over losses of $(0.33) per share
byBill Haddad
November 9, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

Mersana Therapeutics (NASDAQ:MRSN) reported quarterly losses of $(0.63) per share which missed the analyst consensus estimate of $(0.58) by 8.62 percent. This is a 90.91 percent decrease over losses of $(0.33) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts